by Leila MACOR Agence France-Presse MIAMI, United States (AFP) — A little known pharmaceutical company in Florida has found itself in the eye of a storm following disclosures it raised the price of an old drug used to fight brain tumors by 1,400 percent, from $50 a pill to more than $700. NextSource Biotechnology in 2013 bought the license for the drug Lomustine from Bristol-Myers Squibb, which sold a 100-milligram pill of the substance for […]